References
- Abu-Soud H, Hazen S. (2000). Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem 275: 37524-37532.
- Akgul C, Moulding DA, Edwards SW. (2001). Molecular control of neutrophil apoptosis. FEBS Letters 487: 318-322.
- Asbrink S, Zickert A, Bratt J, Gyllenhammar H, Palmblad J. (2000). No eff ect of carvedilol on nitric oxide generation in phagocytes but modulation of production of superoxide ions. Biochem Pharmacol 59: 1007-1013.
- Broskova Z, Drabikova K, Sotnikova R, Fialova S, Knezl V. (2012). Eff ect of plant polyphenols on ischemia-reperfusion injury of the isolated rat heart and vessels. Phytother Res 27: 1018-1022.
- Cascao R, Rosario HS, Souto-Carneiro MM, Fons JE. (2010). Neutrophils in rheumatoid arthritis: More than simple fi nal eff ectors. Autoimm Rev 9: 531-535.
- Ciz M, Komrskova D, Pracharova L, Okenkova K, Cizova H, Moravcova A, Jancinova V, Petrikova M, Lojek A, Nosal R. (2007). Serotonin modulates the oxidative burst of human phagocytes via various mechanisms. Platelets 8: 583-90.
- Drabikova K, Jančinova V, Nosaľ R, Solik P, Murin J, Holomaňova D. (2006). On the antioxidant activity of carvedilol in human polymorphonuclear leukocytes in vitro and ex vivo. Neuroendocrinol Lett 2: 138-140.
- Dulin B, Abraham WT. (2004). Pharmacology of Carvedilol. Am J Cardiol 93: 3-6.
- Filep JG, El Kebir D. (2009). Neutrophil apoptosis: a target for enhancing the resolution of infl ammation. J Cell Biochem 108: 10391046.
- Gomez-Cambronero J, Keire P. (1998.) Phospholipase D: A novel major player in signal transduction. Cell Signall 10: 387397.
- Greene CM, McElvaney NG. (2009). Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery. Brit J Pharmacol 4: 1048-58.
- Jančinova V, Petrikova M, Perečko T, Drabikova K, Nosaľ, Bauerova K, Poništ S, Košťalova D. (2007). Inhibition of neutrophil oxidative burst with arbutin. Effects in vitro and in adjuvant arthritis. Chem Listy 101: 189-191.
- Lau D, Baldus S. (2005). Myeloperoxidase and its contributory role in infl ammatory vascular disease. Pharmacol Ther 111: 16-26.
- Lee HJ, Kim KW. (2012.) Anti-infl ammatory eff ects of arbutin in lipopoly-saccharide- stimulated BV2 microglial cells. Infl amm Res 8: 817-825.
- Mačičkova T, Pečivova J, Nosaľ R, Holomaňova D. (2007). Superoxide generation and myeloperoxidase release in human polymorphonuclear leukocytes treated with carvedilol. Chem Listy 101: 219-221.
- Matsuda H, Nakamura S, Tanaka T, Kubo M. (1991). Combined eff ects of arbutin and indomethacin on immuno-infl ammation. Yakugaku Zasshi 111: 253-58.
- Nakajima K, Powers JC, Ashe BM, Zimmermann M. (1979). Mapping of extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the a1-protease inhibitor reactive site. Biol Chem 254: 4027-4032.
- Nakamura Y, Torikai K, Ohto Y, Murakami A, Tanaka T, Ohigashi H. (2000). A simple phenolic antioxidant protocatechuic acid enhances tumor promotion and oxidative stress in female ICR mouse skin: dose- and timing-dependent enhancement and involvement of bioactivation by tyrosinase. Carcinogenesis 21: 1899-1907.
- Nosaľ R, Jančinova V, Čiž M, Drabikova K, Lojek A, Fabryova V. (2005). Inhibition of chemiluminescence by carvedilol in cell-free system, whole human blood and blood cells. Scand J Clin Lab Invest 65: 55-64.
- Nosaľ R, Jančinova V, Danihelova E. (2000). Chloroquine: a multipotent inhibitor of human platelets in vitro. Thromb Res 98: 411-21.
- Nozawa Y. (2002). Roles of phospholipase D in apoptosis and pro-survival. Biochem Biophys Acta 1585: 77-86.
- Oliver AE, Crowe LM, de Araujo PS, Fisk E, Crowe JH. (1996). Arbutin inhibits PLA2 in partially hydrated model systems. Biocheml Biophys Acta 1: 69-78.
- Pečivova J, Mačičkova T, Svitekova K, Nosaľ R.(2012). Are atypical isoforms of PKC involved in respiratory burst of human neutrophils? Interdiscip Toxicol 5: A62.
- Pečivova J, Nosaľ R, Svitekova K, Mačičkova T. (2011). Possible benefi cial effects of arbutin on attenuation of infl ammation related diseases. Interdiscip Toxicol 4: A53-54.
- Pečivova J, Mačičkova T, Čiž M, Nosaľ R, Fabryova V. (2004 a). Stobadine-modulated human neutrophil functional responsiveness: eff ect of particular and soluble stimulation. Met Find Exp Clin Pharmacol 6: 395-398.
- Pečivova J, Mačičkova T, Čiž M, Nosaľ R, Lojek A. (2004 b). Eff ect of stobadine on opsonized zymosan stimulated generation of reactive oxygen species in human blood cells. Physiol Res 53: 97-102.
- Pečivova J, Mačičkova T, Lojek A , Gallova L, Čiž M, Nosaľ R, Holomaňova D. (2007). In vitro eff ect of carvedilol on professional phagocytes. Pharmacology 2: 86-92.
- Pekarova M, Kralova J, Kubala L, Ciz M, Papezikova I, Macickova T, Pecivova J, Nosal R, Lojek T. (2009). Carvedilol and adrenergic agonists suppress the lipopolysaccharide induced NO production in RAW 264.7 macrophages via the adrenergic receptors. J Physiol Pharmacol 1: 143-150.
- Petrikova M, Jančinova V, Nosaľ R, Majekova M, Danihelova E. (2002). Antiplatelet activity of carvedilol in comparison to propranolol. Platelets 13: 479-485.
- Rios JL, Bas E, Recio MC. (2005). Eff ects of natural products on contact dermatitis. Curr Med Chem - Anti-Infl amm & Anti-Allergy Agents 4: 65-80.
- Serhan CN, Chiang N, Van Dyke TE. (2008). Resolving infl ammation: dual antiinfl ammatory and pro-resolution lipid mediators Nature reviews: Immunl 8: 349-361.
- Stables MJ, Gilroy W. (2011). Old and new generation lipid mediators in acute infl ammation and resolution. Prog Lipid Res 50: 35-51.
- Takebayashi J, Ishii R, Chen J, Matsumoto T, Ishimi Y, Tai A.(2010). Reassessment of antioxidant activity of arbutin: multifaceted evaluation using fi ve antioxidant assay systems. Free Radic Res 4: 473-8.
- Vandivier RW, Fadok VA, Hoff mann PR, Bratton DL, Penvari C, Brown KK, Brain JD, Accurso FJ, Henson PM. (2002.) Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fi brosis and bronchiectasis. J Clin Invest 5: 661-70.
- Von Hundelshausen P, Weber C. (2007). Platelets as immune cells bridging infl ammation and cardiovascular disease. Circul Res 100: 27-40.
- Wachtfogel YT, Kucich UL, James HL, Scott CF, Schapira M, Zimmerman M, Cohen AB, Colman RW. (1983). Human plasma kallikrein releases neutrophil elastase during blood coagulation. J Clin Invest 72: 1672-1677.
- Ward PA, Cunningham TW, Mc Culloch KK, Phan SH, Johnson J. (1988). Platelet enhancement of O2 -. responses in stimulated human neutrophils. Identifi cation of platelet factor as adenine nucleotide. Lab Invest 1: 37-47.
- Weiss SJ, Klein R, Slivka A, Wie M. (1982.) Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest 70: 598-607.
- Yue TL, McKenna PJ, Ruff olo R. Jr., Feuerstein G. (1992). Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils. Eur J Pharmacol 214: 277-280.